Intervention

Sham injection

ClinicalTrials.gov intervention label

Clinical trials14

Recruiting0

Common conditions13

Lead sponsors shown11

Clinical trials

14 shown

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)NCT06270836 · 2024-05-01

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)NCT05066230 · 2021-09-07

Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the EyeNCT04702048 · 2021-02-01

A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)NCT03499223 · 2018-04-20

A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDRNCT02681809 · 2015-12-01

A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) PatientsNCT02259088 · 2014-11-05

A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)NCT03662334 · 2013-10-03

Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With DiabetesNCT01421966 · 2011-08-01

Avastin for PDR (Proliferative Diabetic Retinopathy)NCT01270542 · 2009-06-01

Ranibizumab for Diabetic Traction Retinal DetachmentNCT01201161 · 2008-12-01

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)NCT00473382 · 2007-06-01

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)NCT00473330 · 2007-06-01

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyNCT00445003 · 2007-03-01

A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)NCT00412451 · 2006-12-01

Common conditions

Diabetic Retinopathy5 Diabetes Mellitus3 Diabetic Macular Edema3 Macular Edema3 Retinal Detachment2 Disease Progression1 Lower Extremity Chronic Ulcers in Diabetics1 Non-proliferative Diabetic Retinopathy1 Posterior Vitreous Detachment1 Proliferative Diabetic Retinopathy1 Retinopathy, Diabetic1 Type 1 Diabetes Mellitus1 Visual Impairment1

Leading sponsors

Genentech, Inc.2 Kodiak Sciences Inc2 ThromboGenics2 Halozyme Therapeutics1 Jaeb Center for Health Research1 Macrocure Ltd.1 Novartis Pharmaceuticals1 Oxurion1 University of Rochester1 University of Sao Paulo1 University of Southern California1

Trial status mix

COMPLETED11

TERMINATED2

WITHDRAWN1

Phase mix

PHASE37

PHASE24

PHASE42

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.